Genmab A/S Key Management Personnel Compensation Shortterm Employee Benefits
Genmab A/S (GMAB) reported Key Management Personnel Compensation Shortterm Employee Benefits of $16.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits · last filed 2026-02-17
DKK
| Period end | Key Management Personnel Compensation Shortterm Employee Benefits 12 month |
|---|---|
| 2024-12-31 | 101.00M DKK 6-K · filed 2025-02-12 |
| 2023-12-31 | 71.00M DKK 6-K · filed 2025-02-12 |
| 2022-12-31 | 55.00M DKK 6-K · filed 2025-02-12 |
| 2021-12-31 | 51.00M DKK 6-K · filed 2024-02-14 |
| 2020-12-31 | 48.00M DKK 6-K · filed 2023-02-22 |
| 2019-12-31 | 42.00M DKK 6-K · filed 2022-02-16 |
| 2018-12-31 | 34.00M DKK 6-K · filed 2021-02-23 |
| 2017-12-31 | 39.00M DKK 20-F · filed 2020-03-30 |
USD
| Period end | Key Management Personnel Compensation Shortterm Employee Benefits 12 month |
|---|---|
| 2025-12-31 | $16.00M 20-F · filed 2026-02-17 |
| 2024-12-31 | $15.00M 20-F · filed 2026-02-17 |
| 2023-12-31 | $10.00M 20-F · filed 2026-02-17 |